Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients | Zendy

Shuzo Kobayashi | Zendy; Machiko Oka | Zendy; Kyoko Maesato | Zendy; Ryota Ikee | Zendy; Tsutomu Mano | Zendy; Hidekazu Moriya | Zendy; Takayasu Ohtake | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Coronary Artery Calcification, ADMA, and Insulin Resistance in CKD Patients

Author(s) -

Shuzo Kobayashi,

Machiko Oka,

Kyoko Maesato,

Ryota Ikee,

Tsutomu Mano,

Hidekazu Moriya,

Takayasu Ohtake

Publication year - 2008

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.00010108

Subject(s) - medicine , personal protective equipment , emergency medicine , transmission (telecommunications) , health care , hospital medicine , covid-19 , disease , economic growth , infectious disease (medical specialty) , electrical engineering , economics , engineering

It is known that coronary artery calcification (CAC) develops in chronic kidney disease (CKD) before initiation of renal replacement therapy, and factors associated with CKD mineral and bone disorders (CKD-MBDs) are involved. However, little information is available about any association between plasma levels of asymmetric dimethylarginine (ADMA), insulin resistance, and CAC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research